Semax is a synthetic heptapeptide based on the ACTH(4-10) sequence. Human research has evaluated intranasal Semax in healthy volunteers and in condition-specific neurological studies. The calculations below use the entire 5 mg vial and keep published study protocols separate from worked preparation examples.
